Social trends a ppear a nd dis appear in cyclica l fash ion , wax ing and waning like phases of th e mo on. Societ al a tt it udes, fashi on s, a nd t ren ds reflect t he collect ive id eology a nd mo rality of th e m asses. It is often possible to gene ralize a mo ng man y of th ese trends; he mline length m ay be as reflective of t he socia l clim at e as a tt itudes toward psych oactive drugs. U nfort u na tely, beca use th is climate do es not di scr iminat e, technologic ac hieve me n ts, incl ud ing th erapeutic advances in m edi cin e, ca n fall victim to th e collec t ive societal psych e. This principl e is evide n t in t he fie ld of cli nica l psychopharm acology. This a r t icle explo res changes in pubic pe rcep t ion of psych oactive dru gs in ge ne ra l a nd a nt ia nxie ty age nts in pa r ti cul a r. The re lat ion ship bet wee n public perception of specific pharmacologic age n ts a nd th e abi lit y of ph ysician s to use ag e n ts th a t a lte r beh avior, treat somat ic pai n, a nd mo du lat e sym pto ms of a nx ie ty will be ex plored.
Soc ie t a l attitudes with respect to m ood alt e ri ng drugs have un d ergone pola r shifts throughout th e history of Am erica . In th e nin et eenth ce n t u ry, ma ny of th ese subs tance s, particu larly th e o pia te s a nd cocaine, were conside red be neficia l a nd used as tonics by a ll segmen ts of soc ie ty. Cocaine a nd m or phin e were easily ava ila ble without prescript ion. The incr easin g awaren ess of t he addictive pot ential of t hese drugs eve n t ually ca use d a cha nge in public ac ceptance of narco tics. This decr eased tolerance of psych ot ropi c agen ts bega n in th e la te nin ete en t h century and re ac he d a peak in th e early part of thi s ce nt ury ( I) . The introduction of th e hypodermic needle in th e m id-nine te en t h ce nt ury was quickl y followed by legislation requiring a pr escription to obtain na rco tics. Public fear of th ese age n ts increased as did th e numbers of narco t ic-addi ct ed ind ividu als who used the intravenous rout e. Also , for th e first tim e in Am erican hist o ry, addiction became associat ed in th e public mind with th e health profession. La rge segments of th e population co nfused th e legitimat e use of th ese agents to trea t pain with th e ca re less us e of th ese agents by th e m edical profession a nd also wit h illicit us e not involving ph ysicians. The cava lie r attitude of many ph ysician s wit h respect to narcotics ce r t a inly helped to create this perception. Eu gen e O 'Ne il d ra mat ized his mother's physician-assist ed addiction to morphine in his play, "A Lon g Day'sJou rn ey Into Night " (I) .
A complex mixture of political conse rva tism, religiou s fund am e nt ali sm , and decr eased social tol erance was pervasive in th e Unit ed States during th e latt er part of th e ninet eenth and ea rly tw entieth ce n t ury . This climat e of incr easin g co nce rn about mood-alt ering substances, including alcohol, co n t ribute d to th e 1920' s Proh ibiti on. Additionally, as a result of incr easing public intol erance toward mood-alt e ring substa nces and th e belief that th e health profession was a majo r ca use of addiction , th e Harrison Narcotic Act was adopte d in 1914 (I).
The Harrison Act required strict accounting of opium a nd coca import ation in to th e United States, and rigid co n t rol of th ese subst an ces for medi cal use was facilitated by a tax levied at eac h transfer point. Permits from th e T reasury Dep artm ent had to be obtained by pharmacist s and physicians in o rde r to dispe nse th ese age n ts. The H arrison Act as originally passed pr ohibit ed th e m ai n t e nan ce of " addict io n" exce pt for specific m edical purposes , suc h as pain res ulting from ca nce r or tuberculosis (I).
A major effec t of th e H arrison Act was th e virtual elim ina t ion of opiat es for legitimate m edi cal purposes. Treasury age n ts resp on sibl e for enforcem ent of th e Harrison Act inv estigat ed a nd prosecut ed m an y ph ysicians who prescribed op iat es with mi ssionary-lik e zeal. Between 1915 a nd 1938, ove r 25,000 phys icians were pr osecut ed under the H arrison Act (2) .
During th e 1920s and 1930s, th e use of morphin e a nd he roin decli ned mark edl y in this coun t ry (I). Unfortunately, no body of data exists to document th e effec ts of narcotic restriction on pati ents with se ve re and chro nic pain. It is easy to imagine th e suffering of patients with terminal illn esses wh o were deprived of narcoti c a na lge sics as a result of th e Harrison Act.
Th e Harrison Act signifi ed th e height of psychoactive dru g intoleran ce in th is ce n t ury. Prohibition was rep eal ed in 1933, heralding a change in social a ttitud es. Following World War II and culm ina t ing in th e d ecad es of th e 1960s a nd 1970s, a period of relative tol erance towards psychoactive drug us e again reign ed in th is cou n t ry (I) . Experimentation with many mood-altering subst an ces suc h as ca nnabis a nd hallucinogens became tacitly permitted in many segm ents of soc ie ty ( I).
In th e 1980s and con tinu ing into th e cu r re n t decad e, it a ppears th a t th e pendulum of tolerance is again swing ing tow ard blanket disapproval of a ny psychoactive drug us e (2,3,4). It is int eresting to note that th e cu rre nt co nserva tive social , moral , a nd political climate parall els th at of th e lat e nin et eenth ce ntury and ea rly twentieth ce n t ury.
Additional fu el for th e cu r re nt hei ght en ed conce rn m ay s te m from t he ve ry real problem of "crack " cocaine use. The us e of this ag ent, on e of the most p hysio logically rewarding subs tance s known, has rea ch ed pandemic prop ort ion s (5,6) . The public is con stantly barrag ed with evil associa tions to this drug, suc h as crack houses a nd wid espread cr im e; and in the collective psych e, all " d rugs " (mood-altering subst ances) may become similarly vilified. When epidemiologic trends of drug abuse are st udied, however, it is noted that co nsum ption of many of th e mo od-alt ering subs tances suc h as alcohol, nicotine, ca nna bis, a nd cocaine powd er have ac tua lly decrea sed in rece nt yea rs (5, 6) . Although use of many of th ese subs ta nces is on th e wane, th e " d r ug wa r" continues to escala te as if we are facing a narcotic Armageddon, It is estimate d th at as mu ch as $273 billion a yea r is spe n t to wag e this war, mo stl y related to th e cos ts of arresting and imprisoning drug users (7). Only a very sm all prop ortion of t his huge sum of money is spe n t on addiction re search and substa nce abuse treatment.
Physicians a re having an increasingly difficult tim e using mood-altering agents as part of medical treatment (3, 4, 8) . The health ca re profession s are again viewed by societ y as part of the problem . This ph en om enon is reflect ed in reaction s to perceived misuse of psych otropics by ph ysicians. Ex ampl es of th ese reactions may be found in legislative initiatives, suc h as triplicat e prescripti on regulations. T hese sa nctions create th e viciou s cycle of ph ysicians unwilling to prescribe certain agen ts , which in turn causes a relu ctance by need y patients to as k for th em.
Paradoxically, th e und er-treatment of seve re pain by physicians has re cently been ac knowledged by the Fed eral Governm ent (9) . The Food an d Dru g Administration issu ed a rep ort in t he sp ring of 1992 ad vocating a more judicious use of narcoti cs in th e treatm ent of post ope rative pain a nd pain resulting from chronic and terminal cond itions (9). The con tin ue d under-treatment of pa in may be a vestige of the Harrison Act.
An add itiona l com po ne n t of th e socie tal view of m ood altering drugs may st em fro m th e failure of th e public a nd m any ph ysicians to disti nguish between addicti on a nd dep end en ce. Dep end en ce is a ph ysiological phen omen on whe rein th e presence of a drug is required to m aintain normal fun ctioning. In th e a bse nce of the drug, withdrawal effect s occ u r and th e und erlying dis eas e process may rea pp ea r. Addiction is dep enden ce coupled wit h a pathological need to obta in th e dru g at any cost (7). Addicti on is a characterological phen om en on a nd ofte n resul ts in t he drug-seeking a nd crim inal beh aviors that a re s te reotypica l of th e "addict."
Few people would conside r di ab etics to be addict ed to in suli n, alt hough th ey a re dependent upon this ag ent to maintain norm al fun ctioning. St udies have demonstrate d th at the vast maj ori ty of chro nic pain pati ents usin g na rcotics for long periods of time will be abl e to sto p com ple te ly if th e origin of t he ir pain is eliminated (3). This is in m arked cont rast to the intraven ou s he roin addic ts who tak e t he drug sol ely for it s euphoric effec t and will com mit crimes to obtain th eir next " fix."
The dynamics op erating between society and health ca re pr oviders and patients with respect to th e use of psychotropic m edi cation s is difficult to d elinea te. It is evide n t th at a lternating cycles of tolerance a nd int oleran ce comprise the history of soc ie tal a tt it ude s toward psych oa ctive subs ta nce use in this cou ntry. We will now turn ou r att ention to th e cu r re nt soc ial clim a te a nd it s rela ti onship to the pharmacologic treatmen t of a nxie ty disord ers.
The ex perie nce of anxi ety is a ubiquit ou s ph en om en on of t he human condition. From an evolu tiona ry persp ecti ve, fear, a nx ie ty, a nd eve n panic have consid erable surviva l va lue . H owever, wh en a nx ie ty or it s ph ysiologic m a nifestations becom es severe, unrelenting, and disabling, a person may be face d wit h a serious threat to his or her health and well being.
The conce pt of di stinct anxi et y " diso rde rs" is con tinua lly changing.
Research to d et ermine th e ca uses of a nxie ty di sord ers is taking place rapidly a nd involves m an y di sciplines within psychology, psychi at ry a nd the bas ic neuroscien ces. A significa n t body of knowl ed ge now exists on th e neu ro ch e m ical , neuroanatomica l, a nd psych odynamic d et erminants of anxiety disorde rs.
As a resul t of th ese varied resea rch effor ts, a sim ilar leap has taken place in th e th erap eutic approaches to a nx iety di sorders. Sp ecific pharmacologic ag e nts that hav e a nx iolytic ac tivity have been ava ila ble since th e lat e I 950s . T he tricyclic and mon oam ine oxidase inhibit or a n tide pressa n ts a nd th e ben zodi azepines are all considered sa fe a nd effec tive ph a rmacologic treatm ents for a nxiety disord e rs (13) .
Similar adva nces have tak en place in psychodyn a m ic psych ot he ra pies as well as cog nitive a nd beh avior al approach es to a nxie ty di sord ers. C urrent state-of-the-art t reatm ent of a nx ie ty di sorders usually involves ph a r macothera py in combination wit h some form of psych otherap y a nd possibl y adj unct ive be haviora l or cognitive techniques (13). However, curre n t estimates sugges t that on ly one-quarter of anxi et y dis order patients receive a ny form of t rea t me n t for th eir dist ress (I I) .
Anxiolyt ic m edi cations, particul arly benzodiazep in es, are a pri m a ry modality in th e clinical management of seve re a nxiety di sord ers, ye t rec en t data indicates that t hese ag ents, like t he opi ates, a re considerably unde r-u tili zed in clin ical practice (14, 15) . It is to this issu e whi ch we will now shift the foc us.
Epidemiologic data from th e Unit ed St at es H ou seh old Survey on th e use of Psychotherapeutic M edi cation reveals th at between 1979 a nd 1990, a significant decline occurred in th e use of a nxi olyti c m edi cation s, espec ia lly ben zodi aze pines (14) . This decline occ urred d espite un ch anged preval en ce rat es for a nxiety disorders. It is clear fr om th e d at a that thi s decline in usage ca me a t th e ex pe nse of individuals wit h clini call y sig nifican t a nxie ty disorde rs. Furthermore, the re has not bee n a shift to th e use of alte rna tive med ications or non -pharmacologic th era pies du ring this time period .
Benzodiaz epines have been demon strated to be safe a nd effectiv e ag ents for th e treatment of both acut e and ch ronic anxi et y disord ers ( 15) . Desp it e t he significant declin e in benzodiazepine pr escriptions a nd availa bility in th e las t d ecade, res ervations a bo u t th eir con t inue d us e persist a mong ph ysician s a nd t he gen eral public ( 15) . The dat a fr om se ve ral large cross-sect iona l st ud ies of ben zodi a ze pine us e reveal th a t fears a bo u t th e ove ruse a nd abuse of th ese agen ts is greatly exa gge ra te d ( 15) . Furthermore, th ese fears m ay crea te a climate th at m ay deprive patients of a ppro pria te th erapy. Approximat ely I I percent of Am ericans (14 percent of wo m e n and 8 pe rcent of m en) have us ed a benzodiazepine during th e pr eviou s yea r ( 15) . Th ese data reflect all benzodi a zepine use, including hypn otics for slee p di sorde rs. By co m pa riso n, th e ove ra ll one -year pr eval en ce for ben zodi a zepin e use in ot her W est ern cou nt ries ranges from a high in Belgium of 17.6 percent to a low of 7.4 percent in th e Ne t he rlands . Only 1.7 percent of th e su rvey population in the U.S. used benzodi aze pines dail y for a 12-month period. Two-thirds of th e sa m ple population used th em daily for less th an on e month 's duration (15) . Long-t erm users were mu ch more likely than sho r t-te r m users to be olde r, have high er levels of psych ic dist ress (us ing standardi zed sym pto m checklists for a nxie ty), a nd have more somatic symptom s. Furtherm or e, m an y " me d ica l" probl ems we re chro nic and sev ere, su ch as ca rdiovascula r a nd r he u ma to log ic co nd it io ns. " C hro nic" users of benzodiazepin es are thu s lik ely to be a ppro pria te ca nd idates for th e use of th ese age nts ( 15) .
Benzodiazepine dependence is strikingly low, give n t he large pa t ie nt population s who are expose d to th es e ag ents (15) . Cont rary t o popul ar beli ef, t here are few er patients a bus ing benzodiaz epin es th an would be expecte d fro m th e re lative availabilit y of th ese age nts . Most patients taking a ben zodi a zepi ne for a nxie ty disord er sym pto ms do not show any sym pto ms of add iction or a buse, and in fact, th e reverse is true. Lon g-t erm users of ben zodi a zepines usu all y tak e th eir m ed ication on a n as -neede d ba sis. There is no evide nce th at chro nic use rs exh ibi t co nt in ue d do se esca la t ion. Most lon g-t erm users, in fact , usu all y a t te m pt to see k t he lowest effec t ive dos e to reli eve sym pto ms (15, 16) .
Other indicators of abu se, suc h as recr eation al use, visits to m ultiple physicians see king th e sa me drug, t he overwhel m ing need to use the drug, or sign ifica nt fun cti on al im pairm ent a re vir t ua lly nonexist ent with benzod iazepine users. One st udy profiled hospitali zed ben zodi a zepi ne a buse rs, reveal ing t hat of 1,347 pati ents ad m itted with a subs ta nce a buse di sorder, 136 patients had a primary or secondary di agnosis ofbenzodiaz epin e abuse ( 17) . Benzodi az epin e a busers were likely to hav e a secondary Axi s I di agnosis (45 percent) , with depression most common ( 18 percent ), followed by adj us t me n t disorde r ( 14 percent ), so ma toform disorder (5 percent ), and bip olar di sorder (4 perce nt ). Only 6 perce nt ofbenzod iaze pin e abusers misused th ese age n ts exclus ively ( 17) .
Th e myths a nd mi sp erceptions regarding th e da nge rs of benzodiazepines are easily understood in view of th e cha ng ing popular a tt it udes a nd beliefs tow ards tranquilizers in our societ y. The results of la rge househ old surveys co nduct ed in 1970 a nd again in 1979 reveal several striking t re nds : a lt ho ug h no change in t he perceived efficacy of th ese age n ts occ urred in th e st udy decad e, th e ge ne ral beli ef th at th ese ag ents are unwarrant ed and over-prescribed becam e more co m mo n. In 1970, 61 percent of nonuser respond ents beli eved that do ctors over-prescribed tranqui lizers. This figure incr eased dramaticall y in 1979 to 83 percent (4).
More people (62 percent) in 1979 agreed with th e sta te m e n t, " Using t ra nq uilizers just prevents peopl e from working ou t th eir probl ems for th e mselves," than in 1970 (57 percent). More than 80 percent agre ed with th e sta te me nt, " It is better to use willpower to solv e problems than it is to use tranquilizers. " This figu re remained relatively constant. Int erestingly, 72 percent of nonuser respondents in 1970 and 1979 ag reed with th e statem ent, "Tranquilizers work ve ry well to m ak e a person ca lm and relax ed ." In this same study 60 percent of resp ond ents were un willing to condo ne tranquilizer use wh en seve re a nxie ty sym pto ms result in a loss of job functioning or di sruption of family life (4) .
Th e results of th es e surve ys suggest that a large segme n t of th e popula tion views anxiety disorders as deficits in charac te r rather than dis ease processes. Parad oxicall y, although a majority of th e population believes that anxiolyti c m edi cations work well to alleviat e a nxie ty symptom s, th ey are not willing to co ndo ne t he ir use even in sit ua tions of sig nifica nt impairment.
More recent data reveal that th ese trends con t inue, a nd in fact attitudes toward th e us e of benzodia zepines may have becom e more ri gid ( I I) . Pr eval e nce rat es for benzodiazepine us e co n t inue to decline. Many patients whos e symptoms m erit pharmacologic treatment simply are not receiving th es e age n ts ( I I) . Eq ua lly d ist u rbing is the possibility that many patients wh o have ben efitted from th ese age nts in t he pa st may no longer have access to th em a nd a re receivin g ne it he r alt ernative medi cation nor non-pharmacolo gic t reatm ent.
Legi slative effor ts to limit a nd con trol t he pr escript ion of certain psychotropi cs a re a result of public a tt it udes a bo u t perceived dangers of t hese substances . Th e impact of regulatory effor ts on ph ysician pr escribing pract ices ca n be st ud ied , a nd provid es an indirect gauge of soci etal attitudes that effec t th e medi cal profession .
InJanu ary of 1989, the state of New York issu ed regul ation s requiring t he use of triplicat e prescription procedures for th e clinical us e of ben zodi a zepines (8) . T riplica te pr escriptions a re required in many states fo r di sp en sing Sc he du le II d ru gs (high abuse pot ential). With th e Ne w York legislation , ben zodi a zepines becam e th e only Sch edule IV m edi cation (low pot ential for a buse) to requi re suc h proced u res (4). Contrary to exist ing d ata , th e Ne w York State Departm ent of H ealth stat ed that benzodiazepines are a major public health problem and cite d this as th e major reason for th e decision (4).
A recently publish ed study ha s reviewed th e co nse q ue nces of th e triplicate pr escription regul ation s in New York (8) . From 1988 to 1989, pr escri ptions for benzodi a zepines d ecr eased by 44 percent. H owever, this d ecl ine was accompani ed by a marked incr ease in th e us e of less effec tive a nd more dange rou s subst itut es. For exam ple m eprobamat e us e incr eased by 125 pe rce n t in Ne w York as co m pa re d to a decrease in nation-wid e us e (-9 percent) during th e st udy year. Butibarbital pr escriptions increased by 3 1 percent versus -1 5 percent nationall y (8). Bo th of t hese agents have a high a buse pot ential co upled with a n incr eased risk of fatal ove rdose.
The authors of this study co nclude that mandat ed triplicate pr escr iptions of benzodia ze pines may result in und ertreatment of clinicall y significant anxiet y. Furthermor e, many patients with a nxie ty di sorders m ay receive in appropria te, ineffect ive, a nd pos sibl y dangerou s alte rnatives (8) .
It is clear th at soc ie tal a t tit udes ca n have a se r ious nega tive im pact on clinical practices, es pecia lly in th e realm of psych otropi c m edi cation s. T he implication s of this adverse relation ship are st ag ge ring. The personal distress resu lt ing from und ert re a t me n t of pain and anxiety is apparent. Th e seconda ry effec ts of t his sit ua tion suc h as lost productivity, divorce, a nd suicide rat es a re harder to study a nd qu anti fy. It is distressin g to think that th ese a tt it udes a nd m isp ercept ions may ac t ually hind e r th e development of new a nd safer psych otropi cs. The co ns equ en ces of intole ran ce are felt a t a ll levels of socie ty, including in th e ins tit ut ions and a mo ng scie nt ists cond uc ti ng pharmacologic research.
W e have seen that societ al mi sp erception s a bo u t t he psych o tropic effec ts of a na lge sic and anxiolytic m edications have resulted in und ert reat m e n t of pai n of many typ es and th e particul ar psychi c pain rel at ed to ove rw helming a nxie ty. The relation ship of soc ie tal a tt it udes to th e use of psych ot ro pic ag ents is a subset of t he la rger pr obl em of th e hi st ori cal stigmatizat ion of m ent al illn ess. T his st ig matization co n tin ues unabat ed as we a pproach th e tw e nt y-first ce nt ury. Although we no longer burn th e insan e a t th e stake , mi sp erception s a bo ut t he ca use s a nd treatm ent of m ent al illn ess con t inue tobe rampant. Misinform ation a nd ign oran ce with resp ect to the nature of psychiatric illn ess and the efficacy of so matic t rea t m en ts for th ese cond itio ns will co nt in ue to result in needless suffering .
Ph ysicians ca n help to di sp el th ese m yths at a ll levels of socie ty. This ca n only happen wh en th e m edi cal profession it sel f is read y a nd willin g to de-stigm at ize m ent al illn ess. This process must begin early d urin g m ed ica l ed uca tio n. On ly by incr easing aware ness ca n we hope to end " t he o t he r drug war" and use effec tive m edications unhindered and without fear.
